On behalf of the Endocrine Society’s Oncoendocrinology Special Interest Group, Ling Zhu, MBBChir, discusses her recent paper that addressed “the gap in standardized nomenclature, clinical, laboratory and radiological evaluations, and management principles of endocrine- immune-related adverse events (E-irAEs).” She also talks to corresponding author, Afreen Shariff, MD, about the need for nomenclature, the nature of […]
Towards a Shared Language: Defining Endocrine-Immune-Related Adverse Events
Join the Global Movement Advancing Endocrine Science and Medicine
Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.